Loading...
Dynatronics Corporation
DYNT•NASDAQ
Healthcare
Medical - Devices
$0.10
$0.02(21.92%)
Dynatronics Corporation (DYNT) Financial Performance & Statements
Review Dynatronics Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-19.88%
↓ 19.88%
Operating Income Growth
53.15%
↑ 53.15%
Net Income Growth
52.37%
↑ 52.37%
Operating Cash Flow Growth
-532.90%
↓ 532.90%
Operating Margin
-8.52%
↓ 8.52%
Gross Margin
22.56%
↑ 22.56%
Net Profit Margin
-10.61%
↓ 10.61%
ROE
-22.77%
↓ 22.77%
ROIC
-15.85%
↓ 15.85%
Dynatronics Corporation (DYNT) Financial Statements
Explore quarterly and annual reports for Dynatronics Corporation stock.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $7.30M | $7.60M | $7.37M | $7.66M |
| Cost of Revenue | $5.66M | $5.62M | $5.68M | $5.84M |
| Gross Profit | $1.64M | $1.98M | $1.69M | $1.82M |
| Gross Profit Ratio | $0.23 | $0.26 | $0.23 | $0.24 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.31M | $2.23M | $2.25M | $2.39M |
| Operating Expenses | $2.31M | $2.23M | $2.25M | $2.39M |
| Total Costs & Expenses | $7.97M | $7.85M | $7.93M | $8.23M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $108295.00 | $106348.00 | $118587.00 | $109292.00 |
| Depreciation & Amortization | $264635.00 | $309820.00 | $319930.00 | $332259.00 |
| EBITDA | -$401897.00 | $58824.00 | -$246627.00 | -$239697.00 |
| EBITDA Ratio | -$0.06 | $0.008 | -$0.03 | -$0.03 |
| Operating Income | -$666532.00 | -$250996.00 | -$559891.00 | -$571960.00 |
| Operating Income Ratio | -$0.09 | -$0.03 | -$0.08 | -$0.07 |
| Other Income/Expenses (Net) | -$108295.00 | -$106348.00 | -$125253.00 | -$109292.00 |
| Income Before Tax | -$774827.00 | -$357344.00 | -$685144.00 | -$681248.00 |
| Income Before Tax Ratio | -$0.11 | -$0.05 | -$0.09 | -$0.09 |
| Income Tax Expense | $185612.00 | $9304.00 | $2783.00 | -$13526.00 |
| Net Income | -$774827.00 | -$366648.00 | -$687927.00 | -$851390.00 |
| Net Income Ratio | -$0.11 | -$0.05 | -$0.09 | -$0.11 |
| EPS | -$0.13 | -$0.09 | $0.75 | -$0.17 |
| Diluted EPS | -$0.13 | -$0.09 | $0.75 | -$0.17 |
| Weighted Avg Shares Outstanding | $7.26M | $5.89M | $3.42M | $4.88M |
| Weighted Avg Shares Outstanding (Diluted) | $7.26M | $5.89M | $3.42M | $4.88M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan